Cargando…
Clinical Guideline-Guided Outcome Consistency for Surgically Resected Stage III Non-Small Cell Lung Cancer: A Retrospective Study
SIMPLE SUMMARY: Evidence-based guidelines provide valuable management recommendations that can significantly improve patient treatment and outcome, thereby reducing clinical variability. Recent clinical trials demonstrated that personalised treatments based on genomic and immune profiles can contrib...
Autores principales: | Kuroda, Hiroaki, Sugita, Yusuke, Masago, Katsuhiro, Takahashi, Yusuke, Nakada, Takeo, Sasaki, Eiichi, Sakakura, Noriaki, Yamaguchi, Rui, Matsushita, Hirokazu, Hida, Toyoaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196738/ https://www.ncbi.nlm.nih.gov/pubmed/34064047 http://dx.doi.org/10.3390/cancers13112531 |
Ejemplares similares
-
Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer with ALK Rearrangement
por: Oya, Yuko, et al.
Publicado: (2020) -
Surgical perception of lower tracheal or carinal resection
por: Sugita, Yusuke, et al.
Publicado: (2021) -
Survival benefit of immune checkpoint inhibitor monotherapy in patients with non-small cell lung cancer recurrence after completely pulmonary resection
por: Kuroda, Hiroaki, et al.
Publicado: (2021) -
Permissible Outcomes of Lobe-Specific Lymph Node Dissection for Elevated Carcinoembryonic Antigen in Non-Small Cell Lung Cancer
por: Kuroda, Hiroaki, et al.
Publicado: (2021) -
An extended modification of transmanubrial osteomuscular sparing approach: salvage resection for recurrent superior sulcus lung cancer after definitive chemoradiotherapy
por: Sakakura, Noriaki, et al.
Publicado: (2021)